Skip to content Skip to footer

Macquarie University Health

Brief info

Prof James R. Burrell graduated with a combined Arts/Medicine degree from the University of New South Wales in 2000. He completed basic physicians training at Prince of Wales Hospital, before progressing through advanced training in neurology at Concord and Royal Prince Alfred hospitals. He completed a fellowship in neuromuscular disease and neurophysiology in 2008.
Prof Burrell completed a PhD, based at Neuroscience Research Australia, then took up a position as Senior Research Officer at the same institution from 2012-2016, before moving to the University of Sydney in 2017. His PhD and subsequent research contributions focus on the clinical, neuropsychological, neurophysiological, and neuroimaging characteristics of dementias, with a specific aim of improving diagnostic and prognostic markers. He was previously a Staff Specialist in neurology at Concord Hospital where he was Head of Neurology before being appointed as Professor of Cognitive Neurology at Macquarie University Hospital where he runs a Young Onset Dementia clinic and provides inpatient and outpatient services in general neurology and clinical neurophysiology.

ON THE EDGE: WHO SHOULD BE GETTING MONOCLONAL ANTIBODIES

We live in a brave new world where Alzheimer’s Disease is a biological diagnosis and disease modifying therapies have become available.  However, clinical practice is often not so black and white.  How should we manage the ‘worried well’ who think they should be getting mAb therapy but don’t fulfill criteria?  How much MCI is enough MCI?  Where do logopaenic Alzheimer’s Disease and amyloid positive Posterior Cortical Atrophy fit?  This lecture will seek to address this increasingly complex landscape.